Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page
- Check5 days agoChange DetectedThe page now displays a new footer/version label 'Revision: v3.3.3' and removes ancillary footer links like HHS Vulnerability Disclosure and MedlinePlus Genetics; these changes affect navigation and metadata but do not alter study details or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedPublication section now includes a note that items are automatically filled from PubMed and may not be about the study. The revision version has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check33 days agoChange DetectedThe government funding/operating-status notice at the bottom of the page was removed, removing guidance about potential site-wide delays and where to check for updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check55 days agoChange DetectedThe two screenshots show only minor layout and formatting adjustments to the study details page, with no changes to core study content (title, identifiers, eligibility criteria, design, or outcome measures). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Multiple myeloma, expanding the core content to include genetics-related information on this disease. No deletions. If this is a medical information page, expect broader coverage on genetics and multiple myeloma.SummaryDifference0.2%

- Check77 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.